Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Description

Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.

Conditions

Cutaneous T Cell Lymphoma

Talk to us

Study Overview

On this page

Study Details

Study overview

Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Condition
Cutaneous T Cell Lymphoma
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern University, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Group 1: Patients with stage IA-IIA cutaneous T cell lymphoma
  • * Group 2: Patients with stage IIB and above cutaneous T cell lymphoma
  • * Group 3: Patients with CD30+ lymphoproliferative disorder including lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma
  • * Group 4: Patients with plaque psoriasis with BSA\>5% on routine phototherapy per standard of care
  • * Group 5: Patients with moderate to severe atopic dermatitis on routine bleach bath therapy per standard of care
  • * Group 6: Healthy individuals without the above skin conditions, similar age and sex distribution to the patients with cutaneous T cell lymphoma
  • * All Groups: subjects who are age 18-89 years of age at time of enrollment
  • * All Groups: Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443).
  • * All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
  • * All Groups: Subjects who are unable to give consent
  • * Patients currently on systemic antibiotics or recent (within past 4 weeks) exposure to systemic antibiotics
  • * We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.

Ages Eligible for Study

18 Years to 89 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Northwestern University,

Alan Zhou, MD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

2028-08-31